Alkermes plc Reports First Quarter 2023 Financial Results

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today reported financial results for the first quarter of 2023....

Related Keywords

Ohio ,United States ,Athlone ,Westmeath ,Ireland ,Massachusetts ,Waltham ,Dublin ,Iain Brown ,Katie Joyce ,Sandy Coombs ,Exchange Commission ,Johnson ,Alkermes Inc ,Nasdaq ,Biogen Ma Inc ,Alkermes ,Drug Administration ,Alkermes Pharma Ireland ,First Quarter Revenues ,Reflect Strong Performance ,Proprietary Product Portfolio ,Planned Separation ,Oncology Business Expected ,Second Half ,Second Favorable Interim Award Received ,Janssen Arbitration ,Financial Expectations ,Richard Pops ,Chief Executive Officer ,Chief Financial Officer ,Ended March ,Goods Manufactured ,United States Securities ,Mural Oncology ,Second Interim Award ,Know How Royalty ,Private Securities Litigation Reform Act ,Annual Report ,Alkermes Pharma Ireland Limited ,Financial Information ,Consolidated Statements ,Months Ended ,Earnings Per Share ,Average Number ,Ordinary Shares Outstanding ,Quarterly Report ,Alkermes Plc ,